Indoco Remedies incorporates wholly-owned subsidiary Warren Lifesciences

Indoco Remedies Limited announced the incorporation of its wholly-owned subsidiary, "Warren Lifesciences Private Limited" (WLPL), on September 26, 2026. This follows an approval by the Committee of Executive Directors on September 18, 2026. WLPL is incorporated under the provisions of the Companies Act, 2013, with an authorised share capital of ₹1,00,000, divided into 10,000 equity shares of ₹10 each. Indoco Remedies will hold 100% of WLPL's paid-up share capital through cash consideration. The new subsidiary will operate in the pharmaceutical sector, with the object to manufacture, develop, and sell pharmaceutical products, including active pharmaceutical ingredients, finished formulations, and key starting materials. As a newly incorporated entity, WLPL has no prior turnover. No governmental or regulatory approvals were required for its incorporation.